Methods of viral neutralizing antibody epitope mapping
Disclosed herein are methods of high-throughput mapping of viral neutralizing antibody epitopes. Also disclosed are in vitro immunoprecipitation-based adenoassociated virus Barcode-Seq-based methods of mapping viral neutralizing antibody epitopes. In some embodiments, a method of high-throughput mapping of viral NtAb conformational epitopes can be utilized, which may comprise HP scanning of mutant viral libraries, immunoprecipitation (IP), and/or next-generation sequencing (NGS) technology. In some embodiments, a method of identifying one or more dominant epitopes in a viral vector may comprise contacting a mutant capsid of a virus with serum from a subject previously exposed to the virus and immunopredpitating serum immunoglobulins from the serum. In various embodiments, the viral vector may be an AAV vector.
1. A method of identifying a dominant epitope in a viral vector, the method comprising:
contacting a mutant capsid of an adeno-associated virus (AAV) vector included in a barcoded mutant capsid library with serum from a subject previously exposed to an AAV vector;
immunoprecipitating serum immunoglobulins from the serum; and
sequencing the barcodes in immunoprecipitate, wherein AAV vector mutants bound to the serum immunoglobulins are identified as comprising a dominant epitope.
2. The method of claim 1 , which comprises the step of extracting viral genome DNA from immunoprecipitate.
3. The method of claim 1 , wherein the barcoded mutant capsid library is hexapeptide scanning mutant capsid library.